BRIDGEWATER, N.J.--(BUSINESS WIRE)--Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced its CEO Cancer Gold Standard accreditation, an initiative which represents a significant corporate commitment to the health of employees and their families. To attain accreditation, Enzon has exceeded the scope of typical corporate wellness efforts and met the rigorous requirements of the Gold Standard, taking extensive, concrete actions to promote cancer prevention, early detection, and access to quality care.
